Viridian Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	2,103	1,213	899	976	317	47
Market Cap Growth	71.91%	34.89%	-7.85%	207.65%	573.54%	308.81%
Enterprise Value	1,900	781	777	741	280	32
Last Close Price	21.16	15.40	16.90	24.32	16.17	20.30
PS Ratio	39.94	5028.17	3647.53	663.46	144.94	61.23
PB Ratio	5.62	2.26	2.59	2.98	2.29	0.54
P/TBV Ratio	9.00	3.15	4.86	4.65	7.97	-
EV/Sales Ratio	36.62	3236.51	3150.76	503.65	127.79	41.48
Debt / Equity Ratio	0.05	0.03	0.05	0.01	0.00	0.00
Asset Turnover	0.11	0	0.00	0.01	0.02	0.01
Quick Ratio	11.06	14.99	17.93	12.73	14.48	11.96
Current Ratio	11.28	15.43	18.27	12.93	14.68	12.14
Return on Equity (ROE)	-49.89%	-48.48%	-56.80%	-44.57%	-51.61%	-163.07%
Return on Assets (ROA)	-30.08%	-30.32%	-34.37%	-26.28%	-29.75%	-31.36%
Return on Capital Employed (ROCE)	-61.70%	-43.10%	-54.90%	-33.40%	-41.90%	-33.60%
Earnings Yield	-8.68%	-17.78%	-20.76%	-11.05%	-18.49%	-172.21%
FCF Yield	-11.54%	-15.33%	-16.16%	-8.05%	-12.79%	-46.39%
Buyback Yield / Dilution	-34.66%	-51.68%	-39.48%	-169.22%	-235.07%	-70.27%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.